Considering that NLRC5 and MHC-I could be involved in progressive cancer growth and cancer cell population initiation, those contrary phenomena may result from that NLRC5-elicited antitumor immune response overcoming NLRC5-stimulated cancer growth in cancer cells originating from mice with normal immune function. This evidence concerns the gene NLRC5 and cancer.